verapamil has been researched along with nsc 664704 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brachwitz, K; Hilgeroth, A; Lozach, O; Meijer, L; Molnár, J; Schächtele, C; Voigt, B | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
2 other study(ies) available for verapamil and nsc 664704
| Article | Year |
|---|---|
Evaluation of the first cytostatically active 1-aza-9-oxafluorenes as novel selective CDK1 inhibitors with P-glycoprotein modulating properties.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Aza Compounds; CDC2 Protein Kinase; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorenes; Intercalating Agents; Mice; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |